All Stories

  1. Evidence-based practice in times of drug shortage

    Article • Journal of Oncology Pharmacy Practice, June 2015, SAGE Publications

    Dr Mario L de Lemos

  2. Pharmacy Research by “Nonresearch Pharmacists”

    Article • The Canadian Journal of Hospital Pharmacy, August 2014, Canadian Society of Hospital Pharmacists (CSHP)

    Dr Mario L de Lemos

  3. Clinical efficacy of generic imatinib

    Article • Journal of Oncology Pharmacy Practice, February 2014, SAGE Publications

    Dr Mario L de Lemos

  4. Trastuzumab therapy in breast cancer: To reload or not to reload?

    Article • Journal of Oncology Pharmacy Practice, October 2013, SAGE Publications

    Dr Mario L de Lemos

  5. Hazards in determining whether a drug is hazardous

    Article • Journal of Oncology Pharmacy Practice, August 2013, SAGE Publications

    Dr Mario L de Lemos

  6. Limited Role of Cockcroft–Gault Formula in Dosing Information on Product Labels for Antineoplastic Drugs

    Article • The Canadian Journal of Hospital Pharmacy, August 2013, Canadian Society of Hospital Pharmacists (CSHP)

    Dr Mario L de Lemos

  7. Using expired supply in times of drug shortage

    Article • Journal of Oncology Pharmacy Practice, May 2012, SAGE Publications

    Dr Mario L de Lemos

  8. Comment: Evaluation of the Modified Diet in Renal Disease Equation for Calculation of Carboplatin Dose

    Article • Annals of Pharmacotherapy, October 2009, SAGE Publications

    Dr Mario L de Lemos

  9. Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin

    Article • Journal of Oncology Pharmacy Practice, July 2009, SAGE Publications

    Dr Mario L de Lemos

  10. Use of combined androgen blockade for advanced prostate cancer in British Columbia

    Article • Journal of Oncology Pharmacy Practice, June 2009, SAGE Publications

    Dr Mario L de Lemos

  11. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration

    Article • Journal of Oncology Pharmacy Practice, August 2008, SAGE Publications

    Dr Mario L de Lemos

  12. Impact on patient satisfaction with a structured counselling approach on natural health products

    Article • Journal of Oncology Pharmacy Practice, March 2008, SAGE Publications

    Dr Mario L de Lemos

  13. Interaction between mercaptopurine and milk

    Article • Journal of Oncology Pharmacy Practice, December 2007, SAGE Publications

    Dr Mario L de Lemos

  14. Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation

    Article • Annals of Oncology, September 2007, Oxford University Press (OUP)

    Dr Mario L de Lemos

  15. Communicating With Patients About Chemotherapy Costs

    Article • Journal of Clinical Oncology, April 2007, American Society of Clinical Oncology (ASCO)

    Dr Mario L de Lemos

  16. Stability issues of parenteral chemotherapy drugs

    Article • Journal of Oncology Pharmacy Practice, March 2007, SAGE Publications

    Dr Mario L de Lemos

  17. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies

    Article • Gynecologic Oncology, December 2006, Elsevier

    Dr Mario L de Lemos

  18. Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database

    Article • Journal of Oncology Pharmacy Practice, December 2006, SAGE Publications

    Dr Mario L de Lemos

  19. Potential underdosing of carboplatin in gynecological malignancies

    Article • Gynecologic Oncology, September 2006, Elsevier

    Dr Mario L de Lemos

  20. Acute reactions to chemotherapy agents

    Article • Journal of Oncology Pharmacy Practice, September 2006, SAGE Publications

    Dr Mario L de Lemos

  21. Defining the clinical improvement in cancer drug therapy: implications for priority setting in healthcare

    Article • Journal of Oncology Pharmacy Practice, June 2006, SAGE Publications

    Dr Mario L de Lemos

  22. Management of extravasation of oxaliplatin

    Article • Journal of Oncology Pharmacy Practice, December 2005, SAGE Publications

    Dr Mario L de Lemos

  23. Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions

    Article • Journal of Oncology Pharmacy Practice, December 2005, SAGE Publications

    Dr Mario L de Lemos

  24. Vinorelbine and venous irritation: optimal parenteral administration

    Article • Journal of Oncology Pharmacy Practice, June 2005, SAGE Publications

    Dr Mario L de Lemos

  25. NNT for studies with long-term follow-up

    Article • Canadian Medical Association Journal, March 2005, Canadian Medical Association (CMA)

    Dr Mario L de Lemos

  26. Pharmacist's role in meeting the psychosocial needs of cancer patients using complementary therapy

    Article • Psycho-Oncology, January 2005, Wiley

    Dr Mario L de Lemos

  27. Seeking clarification of osteoporosis guidelines

    Article • Canadian Medical Association Journal, October 2004, Canadian Medical Association (CMA)

    Dr Mario L de Lemos

  28. Rationing costly treatments: can it be fair?

    Article • Journal of Oncology Pharmacy Practice, September 2004, SAGE Publications

    Dr Mario L de Lemos

  29. Effects of flaxseed on breast cancer growth

    Article • Journal of Oncology Pharmacy Practice, September 2004, SAGE Publications

    Dr Mario L de Lemos

  30. Advising Cancer Patients on Natural Health Products— A Structured Approach

    Article • Annals of Pharmacotherapy, September 2004, SAGE Publications

    Dr Mario L de Lemos

  31. Inappropriate Advertising of Dietary Supplements

    Article • New England Journal of Medicine, May 2003, New England Journal of Medicine (NEJM/MMS)

    Dr Mario L de Lemos

  32. Re: Adherence to Therapy With Oral Antineoplastic Agents

    Article • JNCI Journal of the National Cancer Institute, November 2002, Oxford University Press (OUP)

    Dr Mario L de Lemos

  33. How to survive the survival plots

    Article • The Lancet, September 2002, Elsevier

    Dr Mario L de Lemos

  34. Development of a pharmacist-coordinated system of chemotherapy protocols in an integrated healthcare delivery organization

    Article • Journal of Oncology Pharmacy Practice, June 2002, SAGE Publications

    Dr Mario L de Lemos

  35. Herbal Supplement PC-Spes for Prostate Cancer

    Article • Annals of Pharmacotherapy, May 2002, SAGE Publications

    Dr Mario L de Lemos

  36. Effects of Soy Phytoestrogens Genistein and Daidzein on Breast Cancer Growth

    Article • Annals of Pharmacotherapy, September 2001, SAGE Publications

    Dr Mario L de Lemos

  37. A New Ciprofloxacin Stepdown Program in the Treatment of High‐Risk Febrile Neutropenia: A Clinical and Economic Analysis

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, August 2000, Wiley

    Dr Peter John Jewesson, Dr Mario L de Lemos

  38. Application of the area under the curve of carboplatin in predicting toxicity and efficacy

    Article • Cancer Treatment Reviews, December 1998, Elsevier

    Dr Mario L de Lemos